Immunological risk in recipients of kidney transplants from extended criteria donors

Nephrology Dialysis Transplantation

Volumn 25, Issue 8, 2010, Pages 2745-2753

  Diet, Carine ^a   Audard, Vincent ^a   Roudot Thoraval, Franoise ^a   Matignon, Marie ^a   Lang, Philippe ^a   Grimbert, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

immunological risk; marginal donor; renal transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOGENICITY; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETRANSPLANTATION; RETROSPECTIVE STUDY; RISK FACTOR; ADULT; AGED; BIOPSY; CLASSIFICATION; COHORT ANALYSIS; DONOR; GRAFT REJECTION; IMMUNOLOGY; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY; MIDDLE AGED; PATHOLOGY; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY; COHORT STUDIES; FEMALE; GRAFT REJECTION; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 77954778315     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq114     Document Type: Article

References (31)

1. Rosengard BR, Feng S, Alfrey EJ et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002; 2: 701-711
2. Audard V, Matignon M, Dahan K, Lang P, Grimbert P. Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview. Transpl Int 2008; 21: 11-17
3. Nyberg SL, Matas AJ, Kremers WK et al. Improved scoring system to assess adult donors for cadaver renal transplantation. Am J Transplant 2003; 3: 715-721
4. Ojo AO, Hanson JA, Meier-Kriesche H et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589-597
5. Pessione F, Cohen S, Durand D et al. Multivariate analysis of donor risk factors for graft survival in kidney transplantation. Transplantation 2003; 75: 361-367
6. Port FK, Bragg-Gresham JL, Metzger RA et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281-1286
7. Carter JT, Chan S, Roberts JP, Feng S. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center. Am J Transplant 2005; 5: 2745-2753
8. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephrop- athy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181
9. Johnston TD, Thacker LR, Jeon H, Lucas BA, Ranjan D. Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant 2004; 18: 28-32
10. Matsuoka L, Shah T, Aswad S et al. Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor kidney transplantation. Am J Transplant 2006; 6: 1473-1478
11. Melk A, Halloran PF. Cell senescence and its implications for nephrology. J Am Soc Nephrol 2001; 12: 385-393
12. Grinyo JM, Gil-Vernet S, Seron D et al. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant 1998; 13: 2601-2604
13. Zanker B, Schneeberger H, Rothenpieler U et al. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immu- nosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients. Transplantation 1998; 66: 44-49
14. de Fijter JW, Mallat MJ, Doxiadis II et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538-1546
15. Reutzel-Selke A, Jurisch A, Denecke C et al. Donor age intensifies the early immune response after transplantation. Kidney Int 2007; 71: 629-636
16. Frei U, Noeldeke J, Machold-Fabrizii V et al. Prospective age-matching in elderly kidney transplant recipients-a 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50-57
17. Penfield JG, Dawidson IA, Ar'Rajab A, Kielar MA, Jeyarajah DR, Lu CY. Syngeneic renal transplantation increases the number of renal dendritic cells in the rat. Transpl Immunol 1999; 7: 197-200
18. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompat- ibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 1990; 49: 201-207
19. Melk A, Schmidt BM, Braun H et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant 2009; 9: 114-123
20. Garcia GG, Miller RA. Single-cell analyses reveal two defects in pep- tide-specific activation of naive T cells from aged mice. J Immunol 2001; 166: 3151-3157
21. Miller RA, Garcia G, Kirk CJ, Witkowski JM. Early activation defects in T lymphocytes from aged mice. Immunol Rev 1997; 160: 79-90
22. Baltzan M, George D. Renal allograft pathology: the Banff classification. Kidney Int 1999; 56: 1602-1603
23. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004; 364: 1814-1827
24. Moore PS, Farney AC, Sundberg AK et al. Experience with dual kidney transplants from donors at the extremes of age. Surgery 2006; 140: 597-606
25. Keitel E, Michelon T, Dos Santos AF et al. Renal transplants using expanded cadaver donor criteria. Ann Transplant 2004; 9: 23-24
26. Tielen FJ, van Vliet AC, de Geus B, Nagelkerken L, Rozing J. Age- related changes in CD4+ T-cell subsets associated with prolonged skin graft survival in aging rats. Transplant Proc 1993; 25: 28722874
27. Brook MO, Wood KJ, Jones ND. The impact of memory T cells on rejection and the induction of tolerance. Transplantation 2006; 82: 1-9
28. Tesar BM, Du W, Shirali AC, Walker WE, Shen H, Goldstein DR. Aging augments IL-17 T-cell alloimmune responses. Am J Transplant 2009; 9: 54-63
29. Bodingbauer M, Pakrah B, Steininger R et al. The advantage of allocating kidneys from old cadaveric donors to old recipients: a single- center experience. Clin Transplant 2006; 20: 471-475
30. Kasiske BL, Snyder J. Matching older kidneys with older patients does not improve allograft survival. J Am Soc Nephrol 2002; 13: 1067-1072
31. Smits JM, Persijn GG, van Houwelingen HC, Claas FH, Frei U. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant 2002; 2: 664-670